{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T13:41:27Z","timestamp":1784122887140,"version":"3.55.0"},"reference-count":125,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T00:00:00Z","timestamp":1746576000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","award":["\/MICIU\/AEI\/10.13039\/501100011033"],"award-info":[{"award-number":["\/MICIU\/AEI\/10.13039\/501100011033"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","award":["2021SGR0090"],"award-info":[{"award-number":["2021SGR0090"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","award":["PID2022-137541OB-I00"],"award-info":[{"award-number":["PID2022-137541OB-I00"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003030","name":"Ag\u00e8ncia de Gesti\u00f3 d'Ajuts Universitaris i de Recerca","doi-asserted-by":"publisher","award":["2022 FISDU 00004"],"award-info":[{"award-number":["2022 FISDU 00004"]}],"id":[{"id":"10.13039\/501100003030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.neuropharm.2025.110425","type":"journal-article","created":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T21:37:56Z","timestamp":1742420276000},"page":"110425","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Unveiling the potential abuse liability of \u03b1-D2PV: A novel \u03b1-carbon phenyl-substituted synthetic cathinone"],"prefix":"10.1016","volume":"272","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9791-249X","authenticated-orcid":false,"given":"N\u00faria","family":"Nadal-Gratac\u00f3s","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Mata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2542-972X","authenticated-orcid":false,"given":"Pol","family":"Puigseslloses","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgane","family":"De Macedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Lardeux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Pain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu-Hua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liselott","family":"K\u00e4llsten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6627-4501","authenticated-orcid":false,"given":"David","family":"Pubill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5391-5974","authenticated-orcid":false,"given":"Xavier","family":"Berzosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Kehr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Solinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Camarasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Escubedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raul","family":"L\u00f3pez-Arnau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2025.110425_bib1","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1007\/s00213-015-3944-8","article-title":"In vivo potency and efficacy of the novel cathinone \u03b1-pyrrolidinopentiophenone and 3,4-methylenedioxypyrovalerone: self-administration and locomotor stimulation in male rats","volume":"232","author":"Aarde","year":"2015","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2025.110425_bib2","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.neuropharm.2013.04.003","article-title":"The novel recreational drug 3,4-methylenedioxypyrovalerone (MDPV) is a potent psychomotor stimulant: self-administration and locomotor activity in rats","volume":"71","author":"Aarde","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2025.110425_bib3","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1007\/s00213-014-3819-4","article-title":"Binge-like acquisition of 3,4-methylenedioxypyrovalerone (MDPV) self-administration and wheel activity in rats","volume":"232","author":"Aarde","year":"2015","journal-title":"Psychopharmacology (Berl)."},{"key":"10.1016\/j.neuropharm.2025.110425_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.watres.2024.121297","article-title":"Improving wastewater-based epidemiology for new psychoactive substance surveillance by combining a high-throughput in vitro metabolism assay and LC-HRMS metabolite identification","volume":"253","author":"Bade","year":"2024","journal-title":"Water Res."},{"key":"10.1016\/j.neuropharm.2025.110425_bib5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s002130000569","article-title":"Conditioned place preference: what does it add to our preclinical understanding of drug reward?","volume":"153","author":"Bardo","year":"2000","journal-title":"Psychopharmacology (Berl)."},{"key":"10.1016\/j.neuropharm.2025.110425_bib6","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/j.1476-5381.2012.02214.x","article-title":"Use of intracranial self-stimulation to evaluate abuse-related and abuse-limiting effects of monoamine releasers in rats","volume":"168","author":"Bauer","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110425_bib7","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1038\/npp.2011.304","article-title":"The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue","volume":"37","author":"Baumann","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2025.110425_bib8","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1124\/jpet.110.176271","article-title":"In vivo effects of amphetamine analogs reveal evidence for serotonergic inhibition of mesolimbic dopamine transmission in the rat","volume":"337","author":"Baumann","year":"2011","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2025.110425_bib9","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/npp.2012.204","article-title":"Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive \u201cbath salts\u201d products","volume":"38","author":"Baumann","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2025.110425_bib10","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/164_2018_178","article-title":"Neuropharmacology of synthetic cathinones","volume":"252","author":"Baumann","year":"2018","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110425_bib11","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1124\/pr.110.002642","article-title":"The physiology, signaling, and pharmacology of dopamine receptors","volume":"63","author":"Beaulieu","year":"2011","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2025.110425_bib12","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1080\/15563650.2017.1370097","article-title":"Intoxications in the STRIDA project involving a panorama of psychostimulant pyrovalerone derivatives, MDPV copycats","volume":"56","author":"Beck","year":"2018","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.neuropharm.2025.110425_bib13","doi-asserted-by":"crossref","first-page":"865","DOI":"10.3109\/15563650.2015.1089576","article-title":"Intoxications involving MDPV in Sweden during 2010-2014: results from the STRIDA project","volume":"53","author":"Beck","year":"2015","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.neuropharm.2025.110425_bib14","first-page":"636","article-title":"Amphetamine-induced anxiety-related behavior in animal models","volume":"59","author":"Bia\u0142a","year":"2007","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.neuropharm.2025.110425_bib15","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s00213-018-5129-8","article-title":"Scheduling synthetic cathinone substances under the controlled substances Act","volume":"236","author":"Bonson","year":"2019","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2025.110425_bib16","doi-asserted-by":"crossref","first-page":"122","DOI":"10.4062\/biomolther.2016.241","article-title":"The abuse potential of \u03b1-piperidinopropiophenone (PIPP) and \u03b1-piperidinopentiothiophenone (PIVT), two new synthetic cathinones with piperidine ring substituent","volume":"25","author":"Botanas","year":"2017","journal-title":"Biomol. Ther. (Seoul)."},{"key":"10.1016\/j.neuropharm.2025.110425_bib17","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0091-3057(98)00041-0","article-title":"Reinforcing effects of caffeine, ephedrine, and their binary combination in rats","volume":"60","author":"Briscoe","year":"1998","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2025.110425_bib18","doi-asserted-by":"crossref","first-page":"W324","DOI":"10.1093\/nar\/gkae300","article-title":"SwissDock 2024: major enhancements for small-molecule docking with attracting cavities and AutoDock vina","volume":"52","author":"Bugnon","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.neuropharm.2025.110425_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.975820","article-title":"Effects of 3-methylmethcathinone on conditioned place preference and anxiety-like behavior: comparison with methamphetamine","volume":"15","author":"Chen","year":"2022","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110425_bib20","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s00213-017-4526-8","article-title":"Behavioral evidence for the abuse potential of the novel synthetic cathinone alpha-pyrrolidinopentiothiophenone (PVT) in rodents","volume":"234","author":"Cheong","year":"2017","journal-title":"Psychopharmacology (Berl)."},{"key":"10.1016\/j.neuropharm.2025.110425_bib21","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.pbb.2006.09.015","article-title":"Intravenous methamphetamine self-administration in rats: effects of intravenous or intraperitoneal MDMA co-administration","volume":"85","author":"Clemens","year":"2006","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2025.110425_bib22","article-title":"Council Implementing Decision (EU) 2016\/1070 of 27 June 2016 on subjecting 1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one (\u03b1-pyrrolidinovalerophenone, \u03b1-PVP) to control measures","year":"2016","journal-title":"Off. J. Eur. Union"},{"key":"10.1016\/j.neuropharm.2025.110425_bib23","year":"2015","journal-title":"Off. J. Eur. Union"},{"key":"10.1016\/j.neuropharm.2025.110425_bib24","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0014-2999(99)00538-5","article-title":"Inhibition of plasma membrane monoamine transporters by beta-ketoamphetamines","volume":"381","author":"Cozzi","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110425_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2021.113713","article-title":"Effects of synthetic cathinone naphyrone in the conditioned place preference test - evidence of its addictive potential","volume":"421","author":"Danda","year":"2022","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2025.110425_bib26","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1021\/acschemneuro.3c00156","article-title":"Structure-activity relationships for a recently controlled synthetic cathinone dopamine transporter reuptake inhibitor: \u03b1-pyrrolidinohexiophenone (\u03b1-PHP)","volume":"14","author":"Davies","year":"2023","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110425_bib27","doi-asserted-by":"crossref","first-page":"5274","DOI":"10.1073\/pnas.85.14.5274","article-title":"Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats","volume":"85","author":"Di Chiara","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.neuropharm.2025.110425_bib28","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.neuropharm.2018.01.020","article-title":"\u201cEcstasy\u201d to addiction: mechanisms and reinforcing effects of three synthetic cathinone analogs of MDMA","volume":"133","author":"Dolan","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2025.110425_bib29","first-page":"12171","article-title":"Schedules of controlled substances: placement of 10 synthetic cathinones into schedule I. Final rule","volume":"82","author":"Drug Enforcement Administration","year":"2017","journal-title":"Fed. Regist."},{"key":"10.1016\/j.neuropharm.2025.110425_bib30","first-page":"65371","article-title":"Schedules of controlled substances: temporary placement of three synthetic cathinones in Schedule I. Final Order","volume":"76","author":"Drug Enforcement Administration","year":"2011","journal-title":"Fed. Regist."},{"key":"10.1016\/j.neuropharm.2025.110425_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108475","article-title":"Role of amino terminal substitutions in the pharmacological, rewarding and psychostimulant profiles of novel synthetic cathinones","volume":"186","author":"Duart-Castells","year":"2021","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2025.110425_bib33","doi-asserted-by":"crossref","DOI":"10.1111\/bph.16506","article-title":"Sex differences in the effects of N-ethylpentylone in young CD1 mice: insights on behaviour, thermoregulation and early gene expression","volume":"181","author":"Espinosa-Velasco","year":"2024","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110425_bib34","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/npp.2012.233","article-title":"In vivo effects of abused \u201cbath salt\u201d constituent 3,4-methylenedioxypyrovalerone (MDPV) in mice: drug discrimination, thermoregulation, and locomotor activity","volume":"38","author":"Fantegrossi","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2025.110425_bib35","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.tvjl.2017.12.017","article-title":"Rodent analgesia: assessment and therapeutics","volume":"232","author":"Flecknell","year":"2018","journal-title":"Vet. J."},{"key":"10.1016\/j.neuropharm.2025.110425_bib36","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1038\/s41386-018-0209-3","article-title":"The abuse-related effects of pyrrolidine-containing cathinones are related to their potency and selectivity to inhibit the dopamine transporter","volume":"43","author":"Gannon","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2025.110425_bib37","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.neuropharm.2017.08.018","article-title":"Relative reinforcing effects of second-generation synthetic cathinones: acquisition of self-administration and fixed ratio dose-response curves in rats","volume":"134","author":"Gannon","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2025.110425_bib38","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.drugalcdep.2017.06.031","article-title":"Effects of orally self-administered bath salt constituent 3,4-methylenedioxypyrovalerone (MDPV) in mice","volume":"179","author":"Gannon","year":"2017","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2025.110425_bib39","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1124\/jpet.115.223586","article-title":"Comparative behavioral pharmacology of three pyrrolidine-containing synthetic cathinone derivatives","volume":"354","author":"Gatch","year":"2015","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2025.110425_bib40","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/FBP.0b013e328364166d","article-title":"Locomotor stimulant and discriminative stimulus effects of \u201cbath salt\u201d cathinones","volume":"24","author":"Gatch","year":"2013","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110425_bib41","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.brainresbull.2016.04.011","article-title":"Neurobiology of 3,4-methylenedioxypyrovalerone (MDPV) and \u03b1-pyrrolidinovalerophenone (\u03b1-PVP)","volume":"126","author":"Glennon","year":"2016","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2025.110425_bib42","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/BF00433038","article-title":"Progressive ratio and fixed ratio schedules of cocaine-maintained responding in baboons","volume":"65","author":"Griffiths","year":"1979","journal-title":"Psychopharmacology (Berl)."},{"key":"10.1016\/j.neuropharm.2025.110425_bib43","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkr366","article-title":"SwissDock, a protein-small molecule docking web service based on EADock DSS","volume":"39","author":"Grosdidier","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.neuropharm.2025.110425_bib44","doi-asserted-by":"crossref","first-page":"539","DOI":"10.2131\/jts.42.539","article-title":"Alpha-PVP induces the rewarding effect via activating dopaminergic neuron","volume":"42","author":"Hataoka","year":"2017","journal-title":"J. Toxicol. Sci."},{"key":"10.1016\/j.neuropharm.2025.110425_bib45","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000512811","article-title":"A case of alpha-pyrrolidinopentiophenone (Flakka)-Induced ischemic stroke","volume":"13","author":"Heinonen","year":"2021","journal-title":"Case Rep. Neurol."},{"key":"10.1016\/j.neuropharm.2025.110425_bib46","article-title":"Techniques in aseptic rodent surgery","volume":"1","author":"Hoogstraten-Miller","year":"2008","journal-title":"Curr. Protoc. Immunol. Chapter"},{"key":"10.1016\/j.neuropharm.2025.110425_bib47","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.drugalcdep.2012.05.011","article-title":"Contrasting effects of d-methamphetamine, 3,4-methylenedioxymethamphetamine, 3,4-methylenedioxypyrovalerone, and 4-methylmethcathinone on wheel activity in rats","volume":"126","author":"Huang","year":"2012","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2025.110425_bib48","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0306-4522(02)00247-6","article-title":"Ventral striatal anatomy of locomotor activity induced by cocaine, D-amphetamine, dopamine and D1\/D2 agonists","volume":"113","author":"Ikemoto","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2025.110425_bib49","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1007\/s00213-018-4943-3","article-title":"Binge-like acquisition of \u03b1-pyrrolidinopentiophenone (\u03b1-PVP) self-administration in female rats","volume":"235","author":"Javadi-Paydar","year":"2018","journal-title":"Psychopharmacology (Berl)."},{"key":"10.1016\/j.neuropharm.2025.110425_bib50","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1037\/pha0000657","article-title":"Conditioned taste avoidance and conditioned place preference induced by the third-generation synthetic cathinone eutylone in female sprague-dawley rats","volume":"31","author":"Jones","year":"2023","journal-title":"Exp. Clin. Psychopharmacol"},{"key":"10.1016\/j.neuropharm.2025.110425_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2131\/jts.39.1","article-title":"New recreational drug 1-phenyl-2-(1-pyrrolidinyl)-1-pentanone (alpha-PVP) activates central nervous system via dopaminergic neuron","volume":"39","author":"Kaizaki","year":"2014","journal-title":"J. Toxicol. Sci."},{"key":"10.1016\/j.neuropharm.2025.110425_bib52","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.neuropharm.2017.10.007","article-title":"MDPV and \u03b1-PVP use in humans: the twisted sisters","volume":"134","author":"Karila","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2025.110425_bib53","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/bcpt.12253","article-title":"Mephedrone, methylone and 3,4-methylenedioxypyrovalerone (MDPV) induce conditioned place preference in mice","volume":"115","author":"Karlsson","year":"2014","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.neuropharm.2025.110425_bib54","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1111\/j.1476-5381.2011.01499.x","article-title":"Mephedrone, compared with MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and 5-HT levels in nucleus accumbens of awake rats","volume":"164","author":"Kehr","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110425_bib55","series-title":"Compendium of in Vivo Monitoring in Real-Time Molecular Neuroscience","first-page":"193","article-title":"Derivatization chemistries for improved detection of monoamine neurotransmitters and their metabolites in microdialysis samples by liquid chromatography with fluorescence detection, and tandem mass spectrometry","author":"Kehr","year":"2017"},{"key":"10.1016\/j.neuropharm.2025.110425_bib56","first-page":"287","article-title":"Monitoring brain chemical signals by microdialysis","volume":"6","author":"Kehr","year":"2006"},{"key":"10.1016\/j.neuropharm.2025.110425_bib57","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1111\/1556-4029.12202","article-title":"Methylenedioxypyrovalerone (\u201cbath salts\u201d), related death: case report and review of the literature","volume":"58","author":"Kesha","year":"2013","journal-title":"J. Forensic Sci."},{"key":"10.1016\/j.neuropharm.2025.110425_bib58","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1111\/bph.16422","article-title":"The neuropharmacological properties of \u03b1-pyrrolidinobutiothiophenone, a new synthetic cathinone, in rodents; role of the dopaminergic system","volume":"181","author":"Kim","year":"2024","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110425_bib59","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0091-3057(93)90277-Z","article-title":"Effects of amperozide on psychostimulant-induced hyperlocomotion and dopamine release in the nucleus accumbens","volume":"44","author":"Kimura","year":"1993","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2025.110425_bib60","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/7854_2016_32","article-title":"The affective properties of synthetic cathinones: role of reward and aversion in their abuse","volume":"32","author":"King","year":"2017","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110425_bib61","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.pbb.2015.07.013","article-title":"Sex differences in 3,4-methylenedioxypyrovalerone (MDPV)-induced taste avoidance and place preferences","volume":"137","author":"King","year":"2015","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2025.110425_bib62","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.drugalcdep.2014.11.002","article-title":"An assessment of MDPV-induced place preference in adult Sprague-Dawley rats","volume":"146","author":"King","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2025.110425_bib63","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1021\/acschemneuro.5b00160","article-title":"Structural modification of the designer stimulant \u03b1-pyrrolidinovalerophenone (\u03b1-PVP) influences potency at dopamine transporters","volume":"6","author":"Kolanos","year":"2015","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110425_bib64","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1021\/acschemneuro.8b00525","article-title":"DARK classics in chemical neuroscience: \u03b1-pyrrolidinovalerophenone (\u201cFlakka\u201d)","volume":"10","author":"Kolesnikova","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110425_bib65","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0896-6273(00)80557-7","article-title":"Neuroscience of addiction","volume":"21","author":"Koob","year":"1998","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2025.110425_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.forsciint.2024.112297","article-title":"Findings of synthetic cathinones in post-mortem toxicology","volume":"365","author":"Kriikku","year":"2024","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.neuropharm.2025.110425_bib67","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11419-022-00639-5","article-title":"A review of synthetic cathinones emerging in recent years (2019\u20132022)","volume":"41","author":"Kuropka","year":"2022","journal-title":"Forensic Toxicol."},{"key":"10.1016\/j.neuropharm.2025.110425_bib68","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00210-018-1464-x","article-title":"Effect of the combination of mephedrone plus ethanol on serotonin and dopamine release in the nucleus accumbens and medial prefrontal cortex of awake rats","volume":"391","author":"L\u00f3pez-Arnau","year":"2018","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.neuropharm.2025.110425_bib69","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.pnpbp.2017.02.011","article-title":"The combination of MDPV and ethanol results in decreased cathinone and increased alcohol levels. Study of such pharmacological interaction","volume":"76","author":"L\u00f3pez-Arnau","year":"2017","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110425_bib70","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1476-5381.2012.01998.x","article-title":"Comparative neuropharmacology of three psychostimulant cathinone derivatives: butylone, mephedrone and methylone","volume":"167","author":"L\u00f3pez-Arnau","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110425_bib71","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s12024-020-00236-1","article-title":"Fatal \u03b1-PVP and amphetamine poisoning during a sauna and autoerotic practices","volume":"16","author":"Lunetta","year":"2020","journal-title":"Forensic Sci. Med. Pathol."},{"key":"10.1016\/j.neuropharm.2025.110425_bib72","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci13091294","article-title":"Effects of serial polydrug use on the rewarding and aversive effects of the novel synthetic cathinone eutylone","volume":"13","author":"Manke","year":"2023","journal-title":"Brain Sci."},{"key":"10.1016\/j.neuropharm.2025.110425_bib73","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/FBP.0b013e3283123c6c","article-title":"Effect of time-out duration on the reinforcing strength of cocaine assessed under a progressive-ratio schedule in rhesus monkeys","volume":"19","author":"Martelle","year":"2008","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110425_bib74","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.neuropharm.2014.02.016","article-title":"Pharmacology of novel synthetic stimulants structurally related to the \u201cbath salts\u201d constituent 3,4-methylenedioxypyrovalerone (MDPV)","volume":"87","author":"Marusich","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2025.110425_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.173935","article-title":"Alpha-pyrrolidinopentiophenone and mephedrone self-administration produce differential neurochemical changes following short- or long-access conditions in rats","volume":"897","author":"Marusich","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110425_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2019.112211","article-title":"Synthetic cathinone self-administration in female rats modulates neurotransmitter levels in addiction-related brain regions","volume":"376","author":"Marusich","year":"2019","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2025.110425_bib77","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.neuro.2012.08.003","article-title":"Effects of synthetic cathinones contained in \u201cbath salts\u201d on motor behavior and a functional observational battery in mice","volume":"33","author":"Marusich","year":"2012","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuropharm.2025.110425_bib78","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1111\/j.1476-5381.2010.00873.x","article-title":"Guidelines for reporting experiments involving animals: the ARRIVE guidelines","volume":"160","author":"McGrath","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110425_bib79","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1152\/physrev.1998.78.1.189","article-title":"Dopamine receptors: from structure to function","volume":"78","author":"Missale","year":"1998","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuropharm.2025.110425_bib80","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s13181-011-0196-9","article-title":"Death following recreational use of designer drug \u201cbath salts\u201d containing 3,4-Methylenedioxypyrovalerone (MDPV)","volume":"8","author":"Murray","year":"2012","journal-title":"J. Med. Toxicol."},{"key":"10.1016\/j.neuropharm.2025.110425_bib81","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.749429","article-title":"Structure-activity relationship of novel second-generation synthetic cathinones: mechanism of action, locomotion, reward, and immediate-early genes","volume":"12","author":"Nadal-Gratac\u00f3s","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110425_bib82","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23042226","article-title":"Neuropsychopharmacology of emerging drugs of abuse: meta- and para-halogen-ring-substituted \u03b1-PVP (\u201c flakka\u201d) derivatives","volume":"23","author":"Nadal-Gratac\u00f3s","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2025.110425_bib83","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1021\/acschemneuro.2c00772","article-title":"Structure-activity relationship of N-Ethyl-Hexedrone analogues: role of the \u03b1-carbon side-chain length in the mechanism of action, cytotoxicity, and behavioral effects in mice","volume":"14","author":"Nadal-Gratac\u00f3s","year":"2023","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110425_bib84","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejphar.2006.11.075","article-title":"The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain","volume":"559","author":"Nagai","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110425_bib85","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2020.00862","article-title":"Reinforcing effects of the synthetic cathinone \u03b1-pyrrolidinopropiophenone (\u03b1-PPP) in a repeated extended access binge paradigm","volume":"11","author":"Nagy","year":"2020","journal-title":"Front. psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110425_bib86","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/7854_2016_18","article-title":"Decoding the structure of abuse potential for new psychoactive substances: structure-activity relationships for abuse-related effects of 4-substituted methcathinone analogs","volume":"32","author":"Negus","year":"2017","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110425_bib87","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.pbb.2017.04.003","article-title":"Conditioned taste avoidance, conditioned place preference and hyperthermia induced by the second generation \u201cbath salt\u201d \u03b1-pyrrolidinopentiophenone (\u03b1-PVP)","volume":"156","author":"Nelson","year":"2017","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2025.110425_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2019.172762","article-title":"Sex differences in \u03b1-pyrrolidinopentiophenone (\u03b1-PVP)-induced taste avoidance, place preference, hyperthermia and locomotor activity in rats","volume":"185","author":"Nelson","year":"2019","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2025.110425_bib89","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1038\/nn1578","article-title":"Is there a common molecular pathway for addiction?","volume":"8","author":"Nestler","year":"2005","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110425_bib90","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/35053570","article-title":"Molecular basis of long-term plasticity underlying addiction","volume":"2","author":"Nestler","year":"2001","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110425_bib91","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/s41586-024-07804-3","article-title":"Structure of the human dopamine transporter in complex with cocaine","volume":"632","author":"Nielsen","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2025.110425_bib92","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.neubiorev.2010.10.012","article-title":"The predictive validity of the rat self-administration model for abuse liability","volume":"35","author":"O'Connor","year":"2011","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2025.110425_bib93","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/adb.12472","article-title":"The new designer drug buphedrone produces rewarding properties via dopamine D1 receptor activation","volume":"23","author":"Oh","year":"2018","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neuropharm.2025.110425_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2021.113186","article-title":"The acute effects of multiple doses of methamphetamine on locomotor activity and anxiety-like behavior in adolescent and adult mice","volume":"405","author":"Ortman","year":"2021","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2025.110425_bib95","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21218185","article-title":"Flakka: new dangerous synthetic cathinone on the drug scene","volume":"21","author":"Patocka","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2025.110425_bib96","series-title":"The Rat Brain in Stereotaxic Coordinates: Hard Cover Edition","author":"Paxinos","year":"2006"},{"key":"10.1016\/j.neuropharm.2025.110425_bib97","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1080\/02791072.2018.1447172","article-title":"\u201cMarvin, the paranoid android\u201d: the case of an alpha-PVP user in the expanding galaxy of NPS","volume":"50","author":"Pierluigi","year":"2018","journal-title":"J. Psychoact. Drugs"},{"key":"10.1016\/j.neuropharm.2025.110425_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2024.170934","article-title":"Characterising differences between self-reported and wastewater-identified drug use at two consecutive years of an Australian music festival","volume":"921","author":"Puljevi\u0107","year":"2024","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.neuropharm.2025.110425_bib101","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0165-0270(95)00153-0","article-title":"Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy","volume":"66","author":"Richardson","year":"1996","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.neuropharm.2025.110425_bib102","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/ADM.0000000000000407","article-title":"\u03b1-Pyrrolidinopentiophenone (\u201cFlakka\u201d) catalyzing catatonia: a case report and literature review","volume":"12","author":"Richman","year":"2018","journal-title":"J. Addiction Med."},{"key":"10.1016\/j.neuropharm.2025.110425_bib103","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.neubiorev.2018.07.015","article-title":"Abuse potential and toxicity of the synthetic cathinones (i.e., \u201cBath salts\u201d)","volume":"110","author":"Riley","year":"2020","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2025.110425_bib104","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1021\/acs.jcim.3c00054","article-title":"Attracting cavities 2.0: improving the flexibility and robustness for small-molecule docking","volume":"63","author":"R\u00f6hrig","year":"2023","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.neuropharm.2025.110425_bib105","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.amjmed.2012.02.019","article-title":"Psychoactive \u201cbath salts\u201d intoxication with methylenedioxypyrovalerone","volume":"125","author":"Ross","year":"2012","journal-title":"Am. J. Med."},{"key":"10.1016\/j.neuropharm.2025.110425_bib106","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00213-003-1670-0","article-title":"Sex differences in the acquisition of IV methamphetamine self-administration and subsequent maintenance under a progressive ratio schedule in rats","volume":"172","author":"Roth","year":"2004","journal-title":"Psychopharmacology (Berl)."},{"key":"10.1016\/j.neuropharm.2025.110425_bib107","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/npp.2014.325","article-title":"\u201cSecond-generation\u201d mephedrone analogs, 4-MEC and 4-MePPP, differentially affect monoamine transporter function","volume":"40","author":"Saha","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2025.110425_bib108","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1369-1600.2006.00012.x","article-title":"Behavioural assessment of drug reinforcement and addictive features in rodents: an overview","volume":"11","author":"Sanchis-Segura","year":"2006","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neuropharm.2025.110425_bib109","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1007\/s00213-015-4057-0","article-title":"Reinforcing and neurochemical effects of the \u201cbath salts\u201d constituents 3,4-methylenedioxypyrovalerone (MDPV) and 3,4-methylenedioxy-N-methylcathinone (methylone) in male rats","volume":"233","author":"Schindler","year":"2016","journal-title":"Psychopharmacology (Berl)."},{"key":"10.1016\/j.neuropharm.2025.110425_bib110","doi-asserted-by":"crossref","DOI":"10.1111\/adb.12842","article-title":"Stereoselective neurochemical, behavioral, and cardiovascular effects of \u03b1-pyrrolidinovalerophenone enantiomers in male rats","volume":"25","author":"Schindler","year":"2020","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neuropharm.2025.110425_bib111","doi-asserted-by":"crossref","DOI":"10.3791\/52434-v","article-title":"Use of the Open Field Maze to measure locomotor and anxiety-like behavior in mice","author":"Seibenhener","year":"2015","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.neuropharm.2025.110425_bib112","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.neuropharm.2017.11.034","article-title":"Neurocognitive dysfunction following repeated binge-like self-administration of the synthetic cathinone 3,4-methylenedioxypyrovalerone (MDPV)","volume":"134","author":"Sewalia","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2025.110425_bib113","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.euroneuro.2012.09.005","article-title":"Behavioural and neurochemical comparison of chronic intermittent cathinone, mephedrone and MDMA administration to the rat","volume":"23","author":"Shortall","year":"2013","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2025.110425_bib114","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1021\/ac202794q","article-title":"In vivo neurochemical monitoring using benzoyl chloride derivatization and liquid chromatography-mass spectrometry","volume":"84","author":"Song","year":"2012","journal-title":"Anal. Chem."},{"key":"10.1016\/j.neuropharm.2025.110425_bib115","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0006-8993(91)90283-2","article-title":"Effects of cocaine and footshock stress on extracellular dopamine levels in the ventral striatum","volume":"559","author":"Sorg","year":"1991","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2025.110425_bib116","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-24173-x","article-title":"The progressive ratio and fixed ratio 1 schedules of cocaine self-administration in rats convey the same information","volume":"12","author":"Tsibulsky","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2025.110425_bib117","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1369-1600.2007.00070.x","article-title":"Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade","volume":"12","author":"Tzschentke","year":"2007","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neuropharm.2025.110425_bib118","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1369-1600.2012.00474.x","article-title":"Potent rewarding and reinforcing effects of the synthetic cathinone 3,4-methylenedioxypyrovalerone (MDPV)","volume":"19","author":"Watterson","year":"2014","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neuropharm.2025.110425_bib119","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/209875","article-title":"Synthetic cathinones and their rewarding and reinforcing effects in rodents","author":"Watterson","year":"2014","journal-title":"Adv. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110425_bib120","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s11419-018-0409-x","article-title":"Effects of the new generation \u03b1-pyrrolidinophenones on spontaneous locomotor activities in mice, and on extracellular dopamine and serotonin levels in the mouse striatum","volume":"36","author":"Wojcieszak","year":"2018","journal-title":"Forensic Toxicol."},{"key":"10.1016\/j.neuropharm.2025.110425_bib121","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1107\/S2053229624000561","article-title":"Crystal structure and analytical profile of 1,2-diphenyl-2-pyrrolidin-1-ylethanone hydrochloride or \u2018\u03b1-D2PV\u2019: a synthetic cathinone seized by law enforcement, along with its diluent sugar, myo-inositol","volume":"80","author":"Wood","year":"2024","journal-title":"Acta Crystallogr., Sect. C: Struct. Chem."},{"key":"10.1016\/j.neuropharm.2025.110425_bib122","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1093\/jat\/bkw029","article-title":"Twenty-one cases involving alpha-pyrrolidinovalerophenone (\u03b1-PVP)","volume":"40","author":"Wright","year":"2016","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.neuropharm.2025.110425_bib123","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2021.173128","article-title":"Reinforcing and discriminative-stimulus effects of two pyrrolidine-containing synthetic cathinone derivatives in rats","volume":"203","author":"Xu","year":"2021","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2025.110425_bib124","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyv120","article-title":"The effects of 4-methylethcathinone on conditioned place preference, locomotor sensitization, and anxiety-like behavior: a comparison with methamphetamine","volume":"19","author":"Xu","year":"2016","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2025.110425_bib125","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/0091-3057(92)90386-T","article-title":"Anxiogenic effects of acute and chronic cocaine administration: neurochemical and behavioral studies","volume":"41","author":"Yang","year":"1992","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2025.110425_bib126","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000103923","article-title":"Explaining the escalation of drug use in substance dependence: models and appropriate animal laboratory tests","volume":"80","author":"Zernig","year":"2007","journal-title":"Pharmacology"},{"key":"10.1016\/j.neuropharm.2025.110425_bib127","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0306-4522(97)00276-5","article-title":"Parallel strain-dependent effect of amphetamine on locomotor activity and dopamine release in the nucleus accumbens: an in vivo study in mice","volume":"82","author":"Zocchi","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2025.110425_bib128","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/jcc.24249","article-title":"Attracting cavities for docking. Replacing the rough energy landscape of the protein by a smooth attracting landscape","volume":"37","author":"Zoete","year":"2016","journal-title":"J. Comput. Chem."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825001315?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825001315?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T23:58:43Z","timestamp":1762214323000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390825001315"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":125,"alternative-id":["S0028390825001315"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110425","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unveiling the potential abuse liability of \u03b1-D2PV: A novel \u03b1-carbon phenyl-substituted synthetic cathinone","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110425","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"110425"}}